Sector Expert: Danny Deadlock

Danny Deadlock is the founder and publisher of He has over 30 years of experience with Canadian microcap companies listed on the TSX and TSX Venture Exchange.

Recent Interviews

Gout, Kidney Stones, Liver Disease & Cannabinoids (9/15/17)
Medical cannabis

Danny Deadlock, founder of, profiles a company that is working on a novel drug delivery technology with a focus on cannabinoids for the potential to treat various major diseases.

Q4 Correction?: Warnings from Citigroup, HSBC and Morgan Stanley (9/1/17)

Danny Deadlock, founder of, cites evidence that the last quarter of 2017 could be troubled for financial markets.

Recent Quotes

"TLT is worth tucking away for a year to see what evolves."

— Danny Deadlock, Ticker Trax (7/28/14)
more >

"CFO's valuation has dramatic growth potential."

— Danny Deadlock, Stockhouse (9/21/13)
more >

"CFO continues to stand out as a company with tremendous recovery potential."

— Danny Deadlock, Ticker Trax (9/9/13)
more >

"UGD is generating good liquidity; its valuation remains very attractive."

— Danny Deadlock, Ticker Trax (6/10/13)
more >

"SFF has 1.9 Moz in the Measured and Indicated category."

— Danny Deadlock, Ticker Trax (3/30/12)
more >

"SFF's ounces are there and the cash is there."

— Danny Deadlock, Ticker Trax (3/6/12)
more >

"Empire Mine project looks quite promising, should carry even more value"

— Danny Deadlock, (2/28/11)
more >

"Yarumalito will provide the base but El Dovio will provide excitement"

— Danny Deadlock, (2/14/11)
more >

Due to permission requirements, not all quotes are shown.